1. Home
  2. OLMA vs KWR Comparison

OLMA vs KWR Comparison

Compare OLMA & KWR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OLMA
  • KWR
  • Stock Information
  • Founded
  • OLMA 2006
  • KWR 1918
  • Country
  • OLMA United States
  • KWR United States
  • Employees
  • OLMA N/A
  • KWR N/A
  • Industry
  • OLMA Biotechnology: Pharmaceutical Preparations
  • KWR Major Chemicals
  • Sector
  • OLMA Health Care
  • KWR Industrials
  • Exchange
  • OLMA Nasdaq
  • KWR Nasdaq
  • Market Cap
  • OLMA 465.4M
  • KWR 2.5B
  • IPO Year
  • OLMA 2020
  • KWR 1985
  • Fundamental
  • Price
  • OLMA $6.10
  • KWR $138.55
  • Analyst Decision
  • OLMA Strong Buy
  • KWR Strong Buy
  • Analyst Count
  • OLMA 5
  • KWR 3
  • Target Price
  • OLMA $26.25
  • KWR $187.33
  • AVG Volume (30 Days)
  • OLMA 1.2M
  • KWR 146.7K
  • Earning Date
  • OLMA 11-12-2024
  • KWR 10-31-2024
  • Dividend Yield
  • OLMA N/A
  • KWR 1.40%
  • EPS Growth
  • OLMA N/A
  • KWR 647.22
  • EPS
  • OLMA N/A
  • KWR 6.82
  • Revenue
  • OLMA N/A
  • KWR $1,862,709,000.00
  • Revenue This Year
  • OLMA N/A
  • KWR N/A
  • Revenue Next Year
  • OLMA N/A
  • KWR $3.77
  • P/E Ratio
  • OLMA N/A
  • KWR $20.31
  • Revenue Growth
  • OLMA N/A
  • KWR N/A
  • 52 Week Low
  • OLMA $5.56
  • KWR $137.65
  • 52 Week High
  • OLMA $16.78
  • KWR $221.94
  • Technical
  • Relative Strength Index (RSI)
  • OLMA 27.05
  • KWR 24.14
  • Support Level
  • OLMA $5.56
  • KWR $149.74
  • Resistance Level
  • OLMA $6.87
  • KWR $154.46
  • Average True Range (ATR)
  • OLMA 0.81
  • KWR 4.43
  • MACD
  • OLMA -0.28
  • KWR -1.66
  • Stochastic Oscillator
  • OLMA 10.12
  • KWR 3.78

About OLMA Olema Pharmaceuticals Inc.

Olema Pharmaceuticals inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of next generation targeted therapies for women's cancers. Its therapies offer the potential to improve outcomes for women living with cancer. The company has completed discovery and preclinical studies of OP-1250. OP-3136 is another drug candidate in the company's product pipeline.

About KWR Quaker Houghton

Quaker Houghton manufactures and sells a variety of industrial process fluids. The product portfolio of the company includes metal removal fluids, cleaning fluids, corrosion inhibitors, metal drawing and forming fluids, die-cast mold releases, heat treatment and quenchants, metal forging fluids, hydraulic fluids, specialty greases, offshore sub-sea energy control fluids, rolling lubricants, rod and wire drawing fluids and surface treatment chemicals. The geographic segments of the company include America, EMEA, Asia/Pacific, and Global Specialty Businesses. The majority of the revenue is earned from America.

Share on Social Networks: